Micro-Scale Genomic DNA Copy Number Aberrations as Another Means of Mutagenesis in Breast Cancer

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Chao, Hann Hsiang ^a   He, Xiaping ^a,b   Parker, Joel S ^a,b   Zhao, Wei ^a   Perou, Charles M ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MESSENGER RNA;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER SURVIVAL; CARCINOGENESIS; CELL LABELING; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE; GENE DOSAGE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOSS; GENE MUTATION; GENOMICS; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MUTAGENESIS; PROMOTER REGION; PTEN GENE; RNA SEQUENCE; SUM149 GENE;

BREAST NEOPLASMS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; FEMALE; GENE EXPRESSION PROFILING; GENOME, HUMAN; GENOMIC INSTABILITY; HUMANS; MUTAGENESIS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84871286330     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051719     Document Type: Article

References (43)

1. Shen Z, (2011) Genomic instability and cancer: an introduction. J Mol Cell Biol 3: 1-3.
2. Sakakura C, Mori T, Sakabe T, Ariyama Y, Shinomiya T, et al. (1999) Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 24: 299-305.
3. Rowley JD, (1973) Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243: 290-293.
4. Seshadri R, Firgaira FA, Horsfall DJ, McCaul K, Setlur V, et al. (1993) Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group. J Clin Oncol 11: 1936-1942.
5. Seshadri R, Matthews C, Dobrovic A, Horsfall DJ, (1989) The significance of oncogene amplification in primary breast cancer. Int J Cancer 43: 270-272.
6. Pinkel D, Albertson DG, (2005) Array comparative genomic hybridization and its applications in cancer. Nat Genet 37Suppl: S11-17.
7. Tran LM, Zhang B, Zhang Z, Zhang C, Xie T, et al. (2011) Inferring causal genomic alterations in breast cancer using gene expression data. BMC Syst Biol 5: 121.
8. Jarvinen AK, Autio R, Kilpinen S, Saarela M, Leivo I, et al. (2008) High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Genes Chromosomes Cancer 47: 500-509.
9. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, et al. (1999) Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A 96: 9212-9217.
10. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.
11. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences of the United States of America 98: 10869-10874.
12. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, et al. (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100: 8418-8423.
13. Hu Z, Fan C, Oh D, Marron JS, He X, et al. (2006) The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7: 96.
14. Weigman VJ, Chao HH, Shabalin AA, He X, Parker JS, et al. (2012) Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival. Breast Cancer Res Treat.
15. Bergamaschi A, Kim YH, Wang P, Sorlie T, Hernandez-Boussard T, et al. (2006) Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer 45: 1033-1040.
16. Saal LH, Gruvberger-Saal SK, Persson C, Lovgren K, Jumppanen M, et al. (2008) Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet 40: 102-107.
17. Xing F, Persaud Y, Pratilas CA, Taylor BS, Janakiraman M, et al. (2012) Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF. Oncogene 31: 446-457.
18. Ethier SP, Mahacek ML, Gullick WJ, Frank TS, Weber BL, (1993) Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res 53: 627-635.
19. Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, et al. (2009) Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes. J Clin Oncol.
20. Benito M, Parker J, Du Q, Wu J, Xiang D, et al. (2004) Adjustment of systematic microarray data biases. Bioinformatics 20: 105-114.
21. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, et al. (2002) The human genome browser at UCSC. Genome Res 12: 996-1006.
22. Wang K, Singh D, Zeng Z, Coleman SJ, Huang Y, et al. (2010) MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res 38: e178.
23. Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, et al. (2011) Integrative genomics viewer. Nat Biotechnol 29: 24-26.
24. Grabherr MG, Haas BJ, Yassour M, Levin JZ, Thompson DA, et al. (2011) Full-length transcriptome assembly from RNA-Seq data without a reference genome. Nat Biotechnol 29: 644-652.
25. R Development Core Team (2009) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
26. Kristensen GB, Kildal W, Abeler VM, Kaern J, Vergote I, et al. (2003) Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer. Ann Oncol 14: 1494-1500.
27. Trope C, Kaern J, Hogberg T, Abeler V, Hagen B, et al. (2000) Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument. Ann Oncol 11: 281-288.
28. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, et al. (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3.
29. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, et al. (2007) The Genomic Landscapes of Human Breast and Colorectal Cancers. Science.
30. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, et al. (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10: 529-541.
31. Johannsdottir HK, Jonsson G, Johannesdottir G, Agnarsson BA, Eerola H, et al. (2006) Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors. Int J Cancer 119: 1052-1060.
32. Fedele CG, Ooms LM, Ho M, Vieusseux J, O'Toole SA, et al. (2010) Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers. Proc Natl Acad Sci U S A.
33. Van Loo P, Nordgard SH, Lingjaerde OC, Russnes HG, Rye IH, et al. (2010) Allele-specific copy number analysis of tumors. Proc Natl Acad Sci U S A.
34. Russnes HG, Vollan HK, Lingjaerde OC, Krasnitz A, Lundin P, et al. (2010) Genomic architecture characterizes tumor progression paths and fate in breast cancer patients. Sci Transl Med 2: 38ra47.
35. Ding L, Ellis MJ, Li S, Larson DE, Chen K, et al. (2010) Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464: 999-1005.
36. Liu HX, Cartegni L, Zhang MQ, Krainer AR, (2001) A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 27: 55-58.
37. Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM, (1988) An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2: 90-95.
38. Jiang Z, Deng T, Jones R, Li H, Herschkowitz JI, et al. (2010) Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status. J Clin Invest.
39. Herschkowitz JI, He X, Fan C, Perou CM, (2008) The functional loss of the retinoblastoma tumor suppressor is a common event in Basal-like and Luminal B breast carcinomas. Breast Cancer Res 10: R75.
40. Li R, Zhu H, Ruan J, Qian W, Fang X, et al. (2010) De novo assembly of human genomes with massively parallel short read sequencing. Genome Res 20: 265-272.
41. Ajay SS, Parker SC, Abaan HO, Fajardo KV, Margulies EH, (2011) Accurate and comprehensive sequencing of personal genomes. Genome Res 21: 1498-1505.
42. Integrated genomic analyses of ovarian carcinoma. Nature 474: 609-615.
43. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.